Harbin Pharmaceutical Group Co Ltd (600664) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.030x

Based on the latest financial reports, Harbin Pharmaceutical Group Co Ltd (600664) has a cash flow conversion efficiency ratio of -0.030x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-192.19 Million ≈ $-28.12 Million USD) by net assets (CN¥6.41 Billion ≈ $937.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Harbin Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Harbin Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 600664 current and long-term liabilities for a breakdown of total debt and financial obligations.

Harbin Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Harbin Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sichuan Crun Co Ltd SHE:002272	-0.006x
Jiangsu SOPO Chemical Co Ltd SHG:600746	0.039x
Nanobiotix S.A PA:NANO	0.253x
Shenzhen Baoming Technology Co SHE:002992	0.053x
Beijing Cuiwei Tower Co Ltd SHG:603123	-0.031x
Kingenta Ecological Engineering Group Co Ltd SHE:002470	-0.063x
HeBei Jinniu Chemical Industry Co Ltd SHG:600722	0.016x
Jiangsu Jiuding New Material Co Ltd SHE:002201	0.069x

Annual Cash Flow Conversion Efficiency for Harbin Pharmaceutical Group Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Harbin Pharmaceutical Group Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Harbin Pharmaceutical Group Co Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥6.09 Billion ≈ $891.05 Million	CN¥792.50 Million ≈ $115.97 Million	0.130x	-25.68%
2023-12-31	CN¥5.42 Billion ≈ $793.53 Million	CN¥949.67 Million ≈ $138.97 Million	0.175x	+39.38%
2022-12-31	CN¥4.95 Billion ≈ $724.49 Million	CN¥622.09 Million ≈ $91.03 Million	0.126x	+441.93%
2021-12-31	CN¥4.42 Billion ≈ $646.86 Million	CN¥-162.44 Million ≈ $-23.77 Million	-0.037x	+79.87%
2020-12-31	CN¥3.99 Billion ≈ $583.65 Million	CN¥-728.15 Million ≈ $-106.55 Million	-0.183x	-280.76%
2019-12-31	CN¥5.94 Billion ≈ $869.62 Million	CN¥-284.94 Million ≈ $-41.70 Million	-0.048x	-143.47%
2018-12-31	CN¥6.28 Billion ≈ $919.10 Million	CN¥692.72 Million ≈ $101.37 Million	0.110x	+452.97%
2017-12-31	CN¥7.48 Billion ≈ $1.09 Billion	CN¥149.22 Million ≈ $21.84 Million	0.020x	-94.04%
2016-12-31	CN¥8.30 Billion ≈ $1.21 Billion	CN¥2.78 Billion ≈ $406.51 Million	0.335x	+50.91%
2015-12-31	CN¥7.48 Billion ≈ $1.09 Billion	CN¥1.66 Billion ≈ $242.91 Million	0.222x	+71.25%
2014-12-31	CN¥8.77 Billion ≈ $1.28 Billion	CN¥1.14 Billion ≈ $166.25 Million	0.130x	+702.39%
2013-12-31	CN¥8.77 Billion ≈ $1.28 Billion	CN¥141.64 Million ≈ $20.73 Million	0.016x	-74.96%
2012-12-31	CN¥8.65 Billion ≈ $1.27 Billion	CN¥557.83 Million ≈ $81.63 Million	0.064x	+1410.01%
2011-12-31	CN¥6.41 Billion ≈ $938.47 Million	CN¥-31.56 Million ≈ $-4.62 Million	-0.005x	-102.79%
2010-12-31	CN¥6.55 Billion ≈ $957.81 Million	CN¥1.15 Billion ≈ $168.67 Million	0.176x	-43.08%
2009-12-31	CN¥5.98 Billion ≈ $875.69 Million	CN¥1.85 Billion ≈ $270.95 Million	0.309x	+209.57%
2008-12-31	CN¥5.79 Billion ≈ $847.08 Million	CN¥578.59 Million ≈ $84.67 Million	0.100x	-22.30%
2007-12-31	CN¥5.05 Billion ≈ $739.58 Million	CN¥650.16 Million ≈ $95.14 Million	0.129x	-13.48%
2006-12-31	CN¥4.96 Billion ≈ $726.45 Million	CN¥738.08 Million ≈ $108.00 Million	0.149x	-13.82%
2005-12-31	CN¥4.39 Billion ≈ $642.77 Million	CN¥757.76 Million ≈ $110.88 Million	0.173x	+352.24%
2004-12-31	CN¥3.91 Billion ≈ $571.61 Million	CN¥149.01 Million ≈ $21.80 Million	0.038x	-60.58%
2003-12-31	CN¥3.13 Billion ≈ $457.96 Million	CN¥302.83 Million ≈ $44.31 Million	0.097x	-27.37%
2002-12-31	CN¥2.88 Billion ≈ $421.18 Million	CN¥383.44 Million ≈ $56.11 Million	0.133x	-40.95%
2001-12-31	CN¥2.68 Billion ≈ $391.86 Million	CN¥604.13 Million ≈ $88.40 Million	0.226x	-32.31%
2000-12-31	CN¥1.63 Billion ≈ $237.84 Million	CN¥541.70 Million ≈ $79.27 Million	0.333x	+14.09%
1999-12-31	CN¥1.48 Billion ≈ $216.01 Million	CN¥431.22 Million ≈ $63.10 Million	0.292x	+67.75%
1998-12-31	CN¥1.27 Billion ≈ $186.06 Million	CN¥221.41 Million ≈ $32.40 Million	0.174x	--

About Harbin Pharmaceutical Group Co Ltd

SHG:600664 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.39 Billion

CN¥9.47 Billion CNY

Market Cap Rank

#7785 Global

#1957 in China

Share Price

CN¥3.76

Change (1 day)

+2.73%

52-Week Range

CN¥3.23 - CN¥4.44

All Time High

CN¥8.34